Introduction. - Based on a literature review, main ethical and methodologic
al issues raised by the implementation of randomized clinical trials involv
ing elderly patients are discussed.
Current knowledge and key points. - Despite their rapidly growing number an
d the subsequent significant increase in consumption of health care service
s and its cost, elderly patients have seldom been involved in clinical tria
ls.
Future prospects and projects. - However, the need for accurate scientific
information on which relevant therapeutic decisions regarding this vulnerab
le population may be based has introduced marked changes in attitudes towar
ds either clinical trials conducted in the elderly or requirements of vario
us licensing authorities in regard to assessment of new drugs in elderly pa
tients. Although difficulties pertaining to controlled clinical trials invo
lving elderly patients may hamper both planning and carrying out of studies
completion of such trials may be achieved. (C) 2000 Editions scientifiques
et medicales Elsevier SAS.